InvestorsHub Logo

bas2020

02/15/16 10:29 PM

#53894 RE: bas2020 #53891

If I were a fund mgr and had access to mega funds to buy into a promising biotech, I'd be piling in at sub $4, lowering my avg cost as much as possible. If I didn't it would likely be that either the risk/reward was too high to make that investment or I had restrictions on my purchase price.

XenaLives

02/15/16 10:29 PM

#53895 RE: bas2020 #53891

LOL, those numbers are values as of the date of filing.